Related Experiment Video

Updated: Aug 12, 2026

Protocols for Vaginal Inoculation and Sample Collection in the Experimental Mouse Model of Candida vaginitis
07:57

Protocols for Vaginal Inoculation and Sample Collection in the Experimental Mouse Model of Candida vaginitis

Published on: December 8, 2011

Systemic absorption of metronidazole by the vaginal route

M M Alper, B N Barwin, W M McLean

    Obstetrics and Gynecology
    |June 1, 1985
    PubMed

    More Related Videos

    Models of Murine Vaginal Colonization by Anaerobically Grown Bacteria08:53

    Models of Murine Vaginal Colonization by Anaerobically Grown Bacteria

    Published on: May 25, 2022

    Modeling Healthy and Dysbiotic Vaginal Microenvironments in a Human Vagina-on-a-Chip08:15

    Modeling Healthy and Dysbiotic Vaginal Microenvironments in a Human Vagina-on-a-Chip

    Published on: February 16, 2024

    Related Concept Videos

    Drug Absorption: Overview01:17

    Drug Absorption: Overview

    The process of drug absorption signifies the transition of a drug from its site of administration into the plasma. This process is influenced by various factors, including the route of administration, the anatomy of the absorption site, the mechanism of absorption, gut motility, and the drug's physicochemical properties.
    When drugs are injected intravenously, they directly enter the systemic circulation. Alternatively, orally administered drugs navigate through the gastrointestinal (GI) tract.
    Factors Influencing Drug Absorption: Presystemic Elimination01:24

    Factors Influencing Drug Absorption: Presystemic Elimination

    The pharmacokinetic journey of oral drugs begins with a crucial first pass through the hepatic portal system, called the first-pass effect. This first pass significantly impacts bioavailability — the proportion of a drug that enters systemic circulation and is available for therapeutic action. The primary route sees the drug absorbed by intestinal membranes and then shunted to the liver via the hepatic portal vein. Here, pre-systemic elimination occurs as drugs face metabolism or biliary...
    Non-Oral Extravascular Drug Absorption Routes01:15

    Non-Oral Extravascular Drug Absorption Routes

    Non-oral extravascular routes, which encompass sublingual, buccal, topical, intramuscular, and inhalation methods, primarily utilize passive diffusion to transport drugs into the systemic circulation. The absorption rates and effectiveness of these routes depend on the drug's physicochemical properties, as well as the patient's anatomical and pathophysiological state.
    Lipophilic drugs that are stable at salivary pH (6) and exhibit minimal binding to the oral mucosa are absorbed more effectively...
    Microbiota of the Urogenital Tract01:28

    Microbiota of the Urogenital Tract

    The human urogenital system, once thought to be sterile in healthy individuals, is now recognized as a complex microbial habitat. Advancements in molecular sequencing techniques have revealed that even in healthy adults, the kidneys and bladder harbor microbial populations similar to those found in the distal urethra, albeit in much lower abundance. These resident microorganisms, while generally innocuous, can become opportunistic pathogens under conditions that alter the urogenital...
    Candidiasis01:20

    Candidiasis

    Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
    Trichomoniasis01:18

    Trichomoniasis

    Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.